NEW YORK and TORONTO, Jan. 15, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc.
(“iAnthus” or the “Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation
(“MPX”) (CSE: MPX; OTC: MPXEF) are pleased to announce that at the special meeting of MPX securityholders
(“MPX Securityholders”) held today, (the “Meeting”), MPX Securityholders voted
overwhelmingly in favour of a special resolution (the “Arrangement Resolution”) to approve the previously
announced plan of arrangement (the “Arrangement”) under the Business Corporations Act (British Columbia)
between iAnthus and MPX whereby iAnthus will acquire all of the issued and outstanding common shares (the “MPX
Shares”) of MPX pursuant to the terms of an Arrangement Agreement between iAnthus and MPX dated October 18, 2018 (the
“Arrangement Agreement”). Obtaining approval from the MPX Securityholders is one of the primary
conditions to completing the Arrangement.
The Arrangement Resolution required approval by (i) at least two-thirds of the votes cast by holders of MPX
Shares (“MPX Shareholders”) present in person or by proxy at the Meeting, (ii) at least two-thirds of the votes
cast by MPX Securityholders present in person or represented by proxy at the Meeting, voting together as a single class, and (iii)
a majority of the votes cast excluding the votes of MPX Shares held or controlled by “interested parties” as defined under
Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions. At the Meeting, the
Arrangement Resolution was approved by (i) 99.44% of the votes cast by all of the MPX Shareholders eligible to vote at the Meeting,
(ii) 99.55% of the votes cast by all of the MPX Securityholders eligible to vote at the Meeting, voting together as a single class,
and (iii) 99.38% of the votes cast by all of the MPX Shareholders eligible to vote at the Meeting excluding votes of MPX Shares
held or controlled by interested parties. Approximately 40% of the total issued and outstanding MPX Shares were voted in person or
proxy at the Meeting.
In addition, MPX Shareholders approved (i) the continuance of MPX from the Province of Ontario to the Province
of British Columbia prior to the closing of the Arrangement; and (ii) the stock option plan of the newly formed MPX International
Corporation (“MPX International”, formerly 2660528 Ontario Inc.) that will hold all of the non-U.S. businesses of
MPX. MPX International has applied to list its securities on the Canadian Securities Exchange.
It is expected that MPX will apply for a final order of the Supreme Court of British Columbia in respect of the
Arrangement on January 18, 2019. Completion of the Arrangement remains subject to customary closing conditions, which are set out
in the Arrangement Agreement, a copy of which can be found on the SEDAR profiles of iAnthus and MPX at www.sedar.com. Assuming that the conditions to closing of the Arrangement are satisfied or waived, it is expected that
the Arrangement will be completed on or before January 30, 2019. Further information about the Arrangement is set forth in the
materials prepared by MPX in respect of the Meeting, which were mailed to MPX Securityholders and filed under MPX’s profile on
SEDAR at www.sedar.com.
Upon closing, MPX International (MPX’s spun-out company) will hold the non-U.S. assets of MPX, and will be
focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and
marketing products which include cannabinoids as their primary active ingredient. Initial key assets will include Canveda Inc. (a
Canadian Licensed Producer), the Salus BioPharma Corporation agreement with Panaxia Pharmaceutical Industries Ltd. and 50% of a
medical cannabis license application in Australia.
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. owns and operates best-in-class licensed cannabis cultivation, processing and
dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis
industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and health
care services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. The Company uses
these skills to support operations across six states. For more information, visit www.iAnthusCapital.com.
About MPX Bioceutical Corporation
MPX, through its wholly-owned subsidiaries in the U.S., provides substantial management, staffing, procurement,
advisory, financial, real estate rental, logistics and administrative services to three medicinal cannabis enterprises in Arizona
operating under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates
wholesale) brands. The successful Health for Life brand operates in the rapidly growing Phoenix Metropolitan Statistical Area. With
the acquisition of The Holistic Center, MPX added another operating medical cannabis enterprise to its footprint in Arizona.
GreenMart of Nevada NLV, LLC (“GreenMart NV”) is an award-winning licensed cultivation,
production and wholesale business, licensed for both the medical and “adult use” sectors in Las Vegas, Nevada, and is already
selling wholesale into the Nevada medical cannabis market. GreenMart NV has also optioned suitable locations and intends to enter
the higher-margin retail arena by applying for at least two dispensary licenses in the Las Vegas market which will operate under
the “Health for Life” brand.
In Massachusetts, MPX is building out and will operate a cultivation and production facility as well as up to
three dispensaries and manages three full service dispensaries and one producer in Maryland.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and
uncertainties concerning the specific factors disclosed here and elsewhere in iAnthus’ periodic filings with Canadian securities
regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe,
should, our vision” and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, anticipated benefits associated with the acquisition
of MPX, statements with respect to the effect of the Arrangement, the timing for the completion of the Arrangement and the
satisfaction of closing conditions.
The completion of the Arrangement is subject to certain risks, including receipt of applicable regulatory and
court approvals and the satisfaction or waiver of all conditions precedent to the closing of the Arrangement. Accordingly, readers
should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of
the date of this release. iAnthus disclaims any intention or obligation to update or revise such information, except as required by
applicable law, and iAnthus does not assume any liability for disclosure relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news
release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the
securities in the United States. The securities have not been and will not be registered under the United States Securities Act of
1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within
the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an
exemption from such registration is available.
CONTACT INFORMATION FOR IANTHUS CAPITAL HOLDINGS, INC.
Corporate:
Julius Kalcevich
Chief Financial Officer
iAnthus Capital Holdings, Inc.
646-518-9411
Investors@iAnthusCapital.com
US Investors:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
iAnthus@KCSA.com
Canadian Investors:
investors@ianthuscapital.com
Media:
Robert Vanisko
North 6th Agency
212-334-9753 ext.112
iAnthus@n6a.com
CONTACT INFORMATION FOR MPX BIOCEUTICAL CORPORATION
Corporate:
W. Scott Boyes,
Chairman, President and CEO
+1-416-840-4703
info@mpxbioceutical.com
www.mpxbioceutical.com
Investors:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
MPX@KCSA.com
Media Contact:
Anne Donohoe
KCSA Strategic Communications
212-896-1265
adonohoe@kcsa.com
